Skip to content

VACANCY: Internship in Women’s Health R&D

About the Job

The internship will focus on our in vitro diagnostics development work in endometriosis and will involve the following responsibilities: writing research grant proposals, developing project plans, supporting the design and prototyping of our IVD assay, creating technical and scientific documents, defining processes within the product development cycle, outreach to clinical and industry partners to establish international collaborations.

We will provide training in quality management, clinical discovery and product development. The intern will be given the opportunity to work on diverse tasks that have a real impact on healthcare. We offer a hybrid work setup (combination of office-based and remote work).

We are looking for self-motivated, creative and independent people who are keen to see the immediate impact of their work and bring their ideas to life. If you are excited by the possibility of being part of a young startup and making an impact on healthcare, please send your application now!

Required skills and experience:

  • excellent writing and presenting skills
  • process-oriented
  • interest in building relationships
  • very good interpersonal skills
  • self-motivated, flexible
  • Very good English (oral & written)
  • German would be an asset
  • Master’s degree or PhD in Life Sciences or Engineering
  • Allowed to work in Switzerland (Swiss/EU citizen and/or having a valid work permit)

Please send your application, including your cover letter and your CV (in English) to careers@scailyte.com

Call for applications open until Jul 31st, 2022

Starting date: 15th August, 2022

About Scailyte

Scailyte is a globally recognized spin-off from ETH Zürich and pioneer in the field of single-cell data analysis (Nature Spinoff Award, Forbes Top30 in AI, Masschallenge winner, Swiss Top100 Startups). Scailyte’s mission is to discover and develop biomarkers for precision medicine using single-cell data and Artificial Intelligence. Our pioneering technology integrates multimodal single-cell and clinical data to identify novel disease signatures. We are providing innovative solutions for rapid discovery of ultra-sensitive biomarkers for customers in pharma, biotech and clinical research. We are a multidisciplinary multinational team of highly skilled and enthusiastic professionals, offering an inspiring and open-minded environment for career growth. Check out our company video and what our employees say about working at Scailyte: Scailyte Youtube channel.

ScailyteTM and ScaiVisionTM are registered trademarks proprietary to Scailyte AG.

Recent News

Scailyte Extends Series A to USD 8 Million

We are thrilled to announce the extension of our Series A funding, bringing the total raised amount ...

Read more

Recent News

ScaiDigest Volume 6: Variational autoencoders (VAEs) in biology

Welcome to the 6th edition of ScaiDigest, where we explore cutting-edge research in single-cell anal...

Read more

Recent News

Pitch-nic Expo

We're excited to share that our Senior Vice President of Corporate & Technology Development, Corinne...

Read more

Recent News

Targets & Cell Types in Immuno-Oncology Europe 2023

Scailyte is part of Targets & Cell Types in Immuno-Oncology Europe 2023 event on November 14-15 in B...

Read more

Recent News

Unravelling the AI Executive Order: A Discussion with Our CEO and Head of Regulatory Affairs

We invite you to watch this enlightening discussion to gain valuable insights into the evolving AI l...

Read more

Recent News

NextGen Omics 2023

Scailyte is gearing up for NextGen Omics 2023, one of the most scientifically engaging events in Lon...

Read more

Recent News

SITC 2023

Diana Stoycheva and Julian Spagnuolo will be sharing Scailyte’s science at a poster #201, and will...

Read more

Recent News

ScaiDigest Volume 5: Unlocking the Secrets of AML

Read Diana's insightful post and stay at the forefront of scientific advancements in the field!

Read more

Recent News

01 /04

Scailyte Extends Series A to USD 8 Million

We are thrilled to announce the extension of our Series A funding, bringing the total raised amount ...

Read more

ScaiDigest Volume 6: Variational autoencoders (VAEs) in biology

Welcome to the 6th edition of ScaiDigest, where we explore cutting-edge research in single-cell anal...

Read more

Recent News

02 /04

Pitch-nic Expo

We're excited to share that our Senior Vice President of Corporate & Technology Development, Corinne...

Read more

Targets & Cell Types in Immuno-Oncology Europe 2023

Scailyte is part of Targets & Cell Types in Immuno-Oncology Europe 2023 event on November 14-15 in B...

Read more

Recent News

03 /04

Unravelling the AI Executive Order: A Discussion with Our CEO and Head of Regulatory Affairs

We invite you to watch this enlightening discussion to gain valuable insights into the evolving AI l...

Read more

NextGen Omics 2023

Scailyte is gearing up for NextGen Omics 2023, one of the most scientifically engaging events in Lon...

Read more

Recent News

04 /04

SITC 2023

Diana Stoycheva and Julian Spagnuolo will be sharing Scailyte’s science at a poster #201, and will...

Read more

ScaiDigest Volume 5: Unlocking the Secrets of AML

Read Diana's insightful post and stay at the forefront of scientific advancements in the field!

Read more

Recent News